The instruction
for medical use of a product of medical purpose
Laktozhinal
Nazvaniye of a product of medical purpose
Laktozhinal, the vaginal
Structure capsules No. 14 and the description of a product
the Translucent capsules containing powder of beige color
Active component:
the lyophilized culture of lactobacilli of L. casei rhamnosus Doderleini (Lcr35 strain) not less than 1х108, WHICH viable lactobacilli
Excipients: lactoses monohydrate of 5.59 mg, magnesium stearate of 3.41 mg
the Name and (or) the trademark
of the Biose manufacturing organization, France
the Scope
Restoration of vaginal flora at various states:
A bacterial vaginosis (as independent means or as a part of combination therapy),
After use of antibacterial therapy,
By preparation for carrying out planned gynecologic operations,
By prenatal training of the pregnant women entering into risk group concerning a bacterial vaginosis and inflammatory diseases of bodies of a small pelvis.
The action mechanism
At introduction of the LAKTOZhINAL capsule to a vagina a cover of the capsule is dissolved with release of the lyophilized culture of live lactobacilli.
The main mechanism providing protection of a biocenosis of a vagina is the ability of lactobacilli to lactification. It is formed as a result of processing by lactobacilli of a glycogen of a vaginal epithelium and provides maintenance of acidic environment of a vagina which normal makes rn 3.8-4.5. Thus, colonization of a vagina lactobacilli of L. casei rhamnosus Doderleini promotes forming of a protective barrier and maintenance of the normal physiological environment, providing resistance of a vaginal biotope to pathogenic activators.
Lcr35 strain as a part of LAKTOZhINAL has antagonistic activity concerning a wide range pathogenic and opportunistic pathogenic bacteriums (including Staphylococcus spp., Proteus spp., Gardnerella vaginalis, P. bivia and also yeast-like mushrooms of the sort Candida), improves local exchange processes and promotes recovery of natural local immunity.
Inhibiting effect of a strain of Lcr35 (pro-biotic component) as a part of LAKTOZhINAL is characterized by education of antimicrobic agents of type of bacteriocine and peroxide of hydrogen.
A route of administration
the Route of administration - intravaginalno.
To enter the capsule deeply into a vagina, previously having moistened it in a small amount of water for dissolution process acceleration.
LAKTOZhINAL is applied:
on 1 capsule in the morning and in the evening within 7 days or on 1 capsule daily within 14 days. If necessary the course can be repeated.
It can be applied at pregnancy and in the period of a lactation.
Medicinal interactions
Perhaps simultaneous use of antibacterial and antiviral drugs. Clinically significant cases of interaction are not registered.
Side effects (influence, individual intolerance)
Are possible local allergic reactions (including an itching, burning, reddening in genitals, strengthening of mucous discharges from a vagina).
Contraindications for use
For women are younger than 18 years.
Not to use a precautionary measure (safety) in case of hypersensitivity or an allergy to one or more components of a product.
Form of release and packing
Vaginal capsules No. 14. On 7 capsules in 2-circuit strip packagings from a film of polyvinylchloride and aluminum foil, together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not higher than 25 Pages. Out of children's reach.
Expiration date
3 years.
Not to apply after expiry date.
Prescription status
Without prescription
the Name (designation) of the normative document according to which the product of medical purpose
the European Pharmacopoeia
the manufacturing Organization
the Name, the country and also a legal address of the manufacturing organization is made: Biose, France, 15130 of Arpajon sur Cere, France +33 (0) 15587-3000
The name, the address and a contact information (phone, the fax, e-mail) of the organization in the territory of the Republic of Kazakhstan, the accepting claim (offer) on quality of a product of medical purpose from consumers,
responsible for post-registration observation of safety of a product of medical purpose from consumers.
Representative office Bezen Helscare the Czech Republic neuter about in the Republic of Kazakhstan, Almaty, mdt Samal-2, 77A office 3/2
for medical use of a product of medical purpose
Laktozhinal
Nazvaniye of a product of medical purpose
Laktozhinal, the vaginal
Structure capsules No. 14 and the description of a product
the Translucent capsules containing powder of beige color
Active component:
the lyophilized culture of lactobacilli of L. casei rhamnosus Doderleini (Lcr35 strain) not less than 1х108, WHICH viable lactobacilli
Excipients: lactoses monohydrate of 5.59 mg, magnesium stearate of 3.41 mg
the Name and (or) the trademark
of the Biose manufacturing organization, France
the Scope
Restoration of vaginal flora at various states:
A bacterial vaginosis (as independent means or as a part of combination therapy),
After use of antibacterial therapy,
By preparation for carrying out planned gynecologic operations,
By prenatal training of the pregnant women entering into risk group concerning a bacterial vaginosis and inflammatory diseases of bodies of a small pelvis.
The action mechanism
At introduction of the LAKTOZhINAL capsule to a vagina a cover of the capsule is dissolved with release of the lyophilized culture of live lactobacilli.
The main mechanism providing protection of a biocenosis of a vagina is the ability of lactobacilli to lactification. It is formed as a result of processing by lactobacilli of a glycogen of a vaginal epithelium and provides maintenance of acidic environment of a vagina which normal makes rn 3.8-4.5. Thus, colonization of a vagina lactobacilli of L. casei rhamnosus Doderleini promotes forming of a protective barrier and maintenance of the normal physiological environment, providing resistance of a vaginal biotope to pathogenic activators.
Lcr35 strain as a part of LAKTOZhINAL has antagonistic activity concerning a wide range pathogenic and opportunistic pathogenic bacteriums (including Staphylococcus spp., Proteus spp., Gardnerella vaginalis, P. bivia and also yeast-like mushrooms of the sort Candida), improves local exchange processes and promotes recovery of natural local immunity.
Inhibiting effect of a strain of Lcr35 (pro-biotic component) as a part of LAKTOZhINAL is characterized by education of antimicrobic agents of type of bacteriocine and peroxide of hydrogen.
A route of administration
the Route of administration - intravaginalno.
To enter the capsule deeply into a vagina, previously having moistened it in a small amount of water for dissolution process acceleration.
LAKTOZhINAL is applied:
on 1 capsule in the morning and in the evening within 7 days or on 1 capsule daily within 14 days. If necessary the course can be repeated.
It can be applied at pregnancy and in the period of a lactation.
Medicinal interactions
Perhaps simultaneous use of antibacterial and antiviral drugs. Clinically significant cases of interaction are not registered.
Side effects (influence, individual intolerance)
Are possible local allergic reactions (including an itching, burning, reddening in genitals, strengthening of mucous discharges from a vagina).
Contraindications for use
For women are younger than 18 years.
Not to use a precautionary measure (safety) in case of hypersensitivity or an allergy to one or more components of a product.
Form of release and packing
Vaginal capsules No. 14. On 7 capsules in 2-circuit strip packagings from a film of polyvinylchloride and aluminum foil, together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not higher than 25 Pages. Out of children's reach.
Expiration date
3 years.
Not to apply after expiry date.
Prescription status
Without prescription
the Name (designation) of the normative document according to which the product of medical purpose
the European Pharmacopoeia
the manufacturing Organization
the Name, the country and also a legal address of the manufacturing organization is made: Biose, France, 15130 of Arpajon sur Cere, France +33 (0) 15587-3000
The name, the address and a contact information (phone, the fax, e-mail) of the organization in the territory of the Republic of Kazakhstan, the accepting claim (offer) on quality of a product of medical purpose from consumers,
responsible for post-registration observation of safety of a product of medical purpose from consumers.
Representative office Bezen Helscare the Czech Republic neuter about in the Republic of Kazakhstan, Almaty, mdt Samal-2, 77A office 3/2
Related Products
Katalent Italie SpA, the license holder Rekordati Ayrland Ltd. (
Lomeksin 600 mg vaginal capsules 1's
$18.50
Moscow Endocrine Plant (Russia)
Oxytocin-MEZ 5 IU / ml 10s solution for injection in ampoules
$8.00
Out Of Stock
